Follistatin is a multifunctional glycoprotein that has been widely studied in biological research as a regulatory component within signaling networks involving members of the transforming growth factor-beta (TGF-β) superfamily, including myostatin and activins. Through high-affinity binding interactions, follistatin modulates ligand availability and signaling intensity, making it a valuable research subject for understanding how extracellular regulators influence intracellular pathway activation in controlled experimental systems. In laboratory studies, follistatin is examined for its role in coordinating growth- and differentiation-related signaling pathways, particularly those associated with activin- and myostatin-mediated regulation. Research has focused on the biochemical properties of follistatin, including its structural features, isoform diversity, and ligand-binding specificity, as well as its interactions with intracellular signaling pathways such as AKT-associated cascades. These investigations emphasize mechanistic insight into how follistatin participates in complex signaling environments rather than applied or clinical interpretation. Beyond muscle-associated signaling research, follistatin is explored across a broad range of experimental contexts due to its involvement in regulatory processes within multiple tissues. Studies have investigated follistatin-related signaling in bone metabolism–associated pathways, inflammatory signaling networks, metabolic regulation, and adipose tissue–related signaling balance. Such research relies on molecular, cellular, and tissue-level models to analyze pathway modulation, transcriptional responses, and protein expression patterns under defined laboratory conditions.
